About
Kinase Inhibition
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
2,361
By Phase
PHASE1/PHASE2: 1PHASE2/PHASE3: 1PHASE2: 2
By Status
COMPLETED: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04115306Lead Sponsor
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
PHASE1/PHASE2Recruiting
61 participants
Started: Nov 14, 2019 · Completed: Mar 31, 2026
NCT01961934Lead Sponsor
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
PHASE2/PHASE3Withdrawn
Started: May 31, 2014 · Completed: May 31, 2018
NCT01530269Lead Sponsor
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
PHASE2Completed
300 participants
Started: Apr 30, 2012 · Completed: Jan 31, 2019
NCT01304485Lead Sponsor
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
PHASE2Completed
2,000 participants
Started: Apr 30, 2011 · Completed: Jan 31, 2019
Locations (1)
Headquarters
Vancouver, BC, Canada
Map
Loading map...